RU99116091A - 17ALPHA-ACETATE-21-PIVALOATE 17ALPHA, 21-DIHYDROXIPREGN-4-EN-3,20-DION, POSSESSING ANTIALCOAL AND ANXIOLYTIC ACTIVITY - Google Patents
17ALPHA-ACETATE-21-PIVALOATE 17ALPHA, 21-DIHYDROXIPREGN-4-EN-3,20-DION, POSSESSING ANTIALCOAL AND ANXIOLYTIC ACTIVITYInfo
- Publication number
- RU99116091A RU99116091A RU99116091/14A RU99116091A RU99116091A RU 99116091 A RU99116091 A RU 99116091A RU 99116091/14 A RU99116091/14 A RU 99116091/14A RU 99116091 A RU99116091 A RU 99116091A RU 99116091 A RU99116091 A RU 99116091A
- Authority
- RU
- Russia
- Prior art keywords
- 17alpha
- acetate
- dihydroxipregn
- antialcoal
- pivaloate
- Prior art date
Links
- 230000000949 anxiolytic effect Effects 0.000 title claims 2
- 229920004518 DION® Polymers 0.000 title 1
- 239000000126 substance Substances 0.000 claims 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 claims 1
- -1 C-21 steroid Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002075 anti-alcohol Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- JWMFYGXQPXQEEM-WZBAXQLOSA-N pregnane group Chemical group [C@@H]12CC[C@H](CC)[C@@]1(C)CC[C@H]1[C@H]2CCC2CCCC[C@]12C JWMFYGXQPXQEEM-WZBAXQLOSA-N 0.000 claims 1
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99116091/14A RU2171810C2 (en) | 1999-07-21 | 1999-07-21 | DIHYDROXYPREGN-4-ENE-3,20-DIONE 17α-21-PIVALOATE ELICITING ANTIALCOHOLIC AND ANXIOLYTIC ACTIVITY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99116091/14A RU2171810C2 (en) | 1999-07-21 | 1999-07-21 | DIHYDROXYPREGN-4-ENE-3,20-DIONE 17α-21-PIVALOATE ELICITING ANTIALCOHOLIC AND ANXIOLYTIC ACTIVITY |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU99116091A true RU99116091A (en) | 2001-05-10 |
| RU2171810C2 RU2171810C2 (en) | 2001-08-10 |
Family
ID=37500890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU99116091/14A RU2171810C2 (en) | 1999-07-21 | 1999-07-21 | DIHYDROXYPREGN-4-ENE-3,20-DIONE 17α-21-PIVALOATE ELICITING ANTIALCOHOLIC AND ANXIOLYTIC ACTIVITY |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2171810C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2276981C1 (en) * | 2005-02-21 | 2006-05-27 | ГУ Национальный научный центр наркологии МЗ РФ | USING α-ACETATE-21-PYVALOATE-α,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE AS ANTI-MORPHINE AGENT |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2735110A1 (en) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | CORTICOID-17-ALKYLCARBONATE AND METHOD FOR THE PRODUCTION THEREOF |
| US4613463A (en) * | 1984-11-01 | 1986-09-23 | The Upjohn Company | Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid |
| US4761429A (en) * | 1985-07-22 | 1988-08-02 | Kenneth Blum | Enkephalinase and endorphinase inhibitors as anti-craving compositions |
| RU2020937C1 (en) * | 1985-08-05 | 1994-10-15 | Научно-исследовательский институт фармакологии РАМН | Nootropic antialcoholic drug |
| GB8628228D0 (en) * | 1986-11-26 | 1986-12-31 | Inst Biolog Morya Dalnevostoch | Composition inhibiting pathological addiction to alcohol |
| CN1074134A (en) * | 1992-01-10 | 1993-07-14 | I·A·考米沙劳娃 | Pharmaceutical granulated composition and its preparation method |
-
1999
- 1999-07-21 RU RU99116091/14A patent/RU2171810C2/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI974448A7 (en) | Neuroactive steroids of the androstane and pregnane series | |
| Khan et al. | Synthesis and pharmacology of anti-inflammatory steroidal antedrugs | |
| Phillipps | Structure-activity relationships of topically active steroids: the selection of fluticasone propionate | |
| DE10199030I1 (en) | Substituted androsta-1, 4-diene-3, 17-diones and process for their preparation | |
| EP2298316A1 (en) | Therapeutic treatment methods | |
| ATE399174T1 (en) | NEW ANTI-INFLAMMATORY 17.ALPHA.-HETEROCYCLIC ESTERS OF 17.BETA.-CARBOTHIOATE ANDROSTANE DERIVATIVES | |
| EP1867300A3 (en) | Intracorporeal occlusive device | |
| EP0815796A3 (en) | Trocar for laparoscopic operations | |
| EP1055404A3 (en) | A walker | |
| DE69839893D1 (en) | Anti-estrogenic steroids, pharmaceutical compositions and uses thereof | |
| DE60203013D1 (en) | 17ALFA, 21-DIHYDROXYPREGNENE ESTERS AS ANTI-ORGANIC ACTIVE SUBSTANCES | |
| DE69008401D1 (en) | 19-Nor, 3-keto steroids with an amino-substituted chain, process for their preparation, intermediates and pharmaceutical preparations thereof. | |
| Popper et al. | Structure-activity relationships of a series of novel topical corticosteroids | |
| Katz et al. | Topical corticosteroids, structure‐activity and the glucocorticoid receptor: Discovery and development—A process of “planned serendipity” | |
| Shafagoj et al. | Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats | |
| GB1494097A (en) | D-homo-20-keto-pregnanes | |
| RU99116091A (en) | 17ALPHA-ACETATE-21-PIVALOATE 17ALPHA, 21-DIHYDROXIPREGN-4-EN-3,20-DION, POSSESSING ANTIALCOAL AND ANXIOLYTIC ACTIVITY | |
| RU99116090A (en) | 17ALPHA, 21-DIACETATE 17ALPHA, 21-DIHYDROXIPREGN-4-EN-3,20-DION, POSSESSING ANTI-ALCOHOL AND ADAPTOGENIC ACTIVITY | |
| Khan et al. | Antedrugs: an approach to safer drugs | |
| Nacht et al. | Effects of corticosteroids on connective tissue and fibroblasts | |
| KR970706297A (en) | NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS for inducing hypothalamic efficacy | |
| Mitsuhiro et al. | Induction of peroxisomal β-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships | |
| Lebrec et al. | Mechanisms of drug-induced allergic contact dermatitis | |
| JPS60161998A (en) | 1 alpha,2 alpha-methylene-6-methylene- or 6 alpha-methyl-pregnene, manufacture and antiandrogenic for local effect of skin disease treatment | |
| US3112305A (en) | 6-methylene-3-oxo-delta4-steroids and process for their preparation |